Goldman Sachs’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$786K Sell
798,754
-728,532
-48% -$717K ﹤0.01% 3988
2025
Q1
$2.2M Sell
1,527,286
-1,225,974
-45% -$1.77M ﹤0.01% 3305
2024
Q4
$6.06M Buy
2,753,260
+1,445,592
+111% +$3.18M ﹤0.01% 2706
2024
Q3
$2.16M Buy
1,307,668
+391,657
+43% +$646K ﹤0.01% 3319
2024
Q2
$2.03M Sell
916,011
-2,448,255
-73% -$5.44M ﹤0.01% 3176
2024
Q1
$9.02M Buy
3,364,266
+2,306,865
+218% +$6.18M ﹤0.01% 2130
2023
Q4
$3.16M Sell
1,057,401
-119,595
-10% -$358K ﹤0.01% 2914
2023
Q3
$1.15M Buy
1,176,996
+351,285
+43% +$344K ﹤0.01% 3448
2023
Q2
$1.15M Buy
825,711
+124,550
+18% +$173K ﹤0.01% 3537
2023
Q1
$1.11M Sell
701,161
-27,177
-4% -$43.2K ﹤0.01% 3593
2022
Q4
$4.54M Buy
728,338
+262,539
+56% +$1.64M ﹤0.01% 2699
2022
Q3
$3.12M Buy
465,799
+204,241
+78% +$1.37M ﹤0.01% 3014
2022
Q2
$1.66M Sell
261,558
-107,953
-29% -$687K ﹤0.01% 3579
2022
Q1
$1.72M Buy
369,511
+82,242
+29% +$382K ﹤0.01% 3691
2021
Q4
$1.44M Buy
287,269
+259,716
+943% +$1.3M ﹤0.01% 3746
2021
Q3
$332K Sell
27,553
-10,931
-28% -$132K ﹤0.01% 4603
2021
Q2
$814K Buy
38,484
+20,766
+117% +$439K ﹤0.01% 4147
2021
Q1
$497K Sell
17,718
-80,495
-82% -$2.26M ﹤0.01% 4365
2020
Q4
$2.55M Buy
98,213
+52,744
+116% +$1.37M ﹤0.01% 2918
2020
Q3
$1.69M Sell
45,469
-266,692
-85% -$9.91M ﹤0.01% 3002
2020
Q2
$16M Buy
312,161
+75,275
+32% +$3.86M ﹤0.01% 1614
2020
Q1
$7.47M Sell
236,886
-168,925
-42% -$5.33M ﹤0.01% 1992
2019
Q4
$24.2M Buy
405,811
+114,392
+39% +$6.82M 0.01% 1494
2019
Q3
$10.7M Sell
291,419
-145,949
-33% -$5.35M ﹤0.01% 1894
2019
Q2
$20.3M Sell
437,368
-27,765
-6% -$1.29M 0.01% 1570
2019
Q1
$18.7M Buy
465,133
+135,796
+41% +$5.45M 0.01% 1655
2018
Q4
$15.1M Buy
329,337
+94,319
+40% +$4.34M ﹤0.01% 1693
2018
Q3
$10.4M Buy
235,018
+20,005
+9% +$888K ﹤0.01% 2030
2018
Q2
$8.43M Buy
215,013
+27,015
+14% +$1.06M ﹤0.01% 2095
2018
Q1
$13.6M Sell
187,998
-143,078
-43% -$10.3M ﹤0.01% 1758
2017
Q4
$21.8M Buy
331,076
+71,980
+28% +$4.74M 0.01% 1514
2017
Q3
$13M Buy
259,096
+9,485
+4% +$475K ﹤0.01% 1825
2017
Q2
$11.6M Buy
249,611
+187,728
+303% +$8.69M ﹤0.01% 1854
2017
Q1
$2.19M Buy
61,883
+19,654
+47% +$694K ﹤0.01% 2679
2016
Q4
$529K Sell
42,229
-7,493
-15% -$93.9K ﹤0.01% 3420
2016
Q3
$689K Buy
49,722
+1,710
+4% +$23.7K ﹤0.01% 3257
2016
Q2
$474K Buy
48,012
+7,000
+17% +$69.1K ﹤0.01% 3345
2016
Q1
$694K Sell
41,012
-1,019
-2% -$17.2K ﹤0.01% 3044
2015
Q4
$936K Buy
42,031
+21,991
+110% +$490K ﹤0.01% 2932
2015
Q3
$473K Buy
20,040
+8,553
+74% +$202K ﹤0.01% 3344
2015
Q2
$939K Sell
11,487
-4,668
-29% -$382K ﹤0.01% 2980
2015
Q1
$1.5M Buy
16,155
+10,479
+185% +$970K ﹤0.01% 2695
2014
Q4
$230K Buy
+5,676
New +$230K ﹤0.01% 3887
2014
Q1
Sell
-11,819
Closed -$162K 4339
2013
Q4
$162K Sell
11,819
-4,933
-29% -$67.6K ﹤0.01% 3959
2013
Q3
$316K Buy
+16,752
New +$316K ﹤0.01% 3590